Acadian Asset Management
BIOA

Acadian Asset Management’s BioAge Labs BIOA Stock Holding History

Acadian Asset Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Sell
224,453
-167,893
-43% -$3.03M 0.01% 775
2026
Q1 		$6.86M Buy
392,346
+114,389
+41% +$2.2M 0.01% 619
2025
Q4 		$3.67M Buy
277,957
+267,281
+2,504% +$2.37M 0.01% 733
2025
Q3 		$61K Buy
10,676
+7,738
+263% +$36.2K ﹤0.01% 1614
2025
Q2 		$12K Buy
+2,938
New +$11.8K ﹤0.01% 1607

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Acadian Asset Management's BIOA Position: Q2 2026 in Review

Acadian Asset Management reduced its BioAge Labs (BIOA) stake by 43% in Q2 2026, selling an estimated $3.03M and leaving 224,453 shares worth $5.5M. The position accounts for 0.01% of the portfolio, ranked #775.

Acadian Asset Management first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.86M in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Acadian Asset Management held 224,453 shares of BioAge Labs worth $5.5M as of Q2 2026.
  • Acadian Asset Management sold 167,893 BioAge Labs shares in Q2 2026, an estimated $3.03M.
  • BioAge Labs made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #775 holding.
  • Acadian Asset Management first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • Acadian Asset Management's BioAge Labs position peaked at $6.86M in Q1 2026.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.